GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were overweight or had obesity.

Researchers at VCU Massey Comprehensive Cancer Center have developed a new computational tool called Vesalius, which could ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

Novocure (NASDAQ: NVCR) announced today that Spain’s Ministry of Health has made Tumor Treating Fields (TTFields) therapy ...

Monty Python star, Eric Idle, has shared the truth behind his unlikely response to his cancer diagnosis. The 82-year-old was ...

Company’s pembrolizumab-based immune checkpoint inhibitor exhibited success against solid tumors in IND-enabling studies by ...

University of Arizona researchers have come up with a new way to deliver chemotherapy drugs to pancreatic and breast cancer ...

Propanc Biopharma Inc. (PPCB) completed an initial public offering and began trading on the Nasdaq Capital Market on August 15. The biopharmaceutical company raised $4 million through the sale of 1 ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) ('Propanc” or the 'Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today ...

Eric Idle has reflected on being diagnosed with pancreatic cancer, revealing he “laughed” when he discovered the news. After ...